An Italian Cost-effectiveness Analysis of Paclitaxel Albumin (nab Paclitaxel) Vs Solvent-based Paclitaxel for Metastatic Breast Cancer Patients - the CONSTANZA Study

被引:0
|
作者
Lazzaro, C. [1 ]
Bordonaro, R. [2 ]
Cognetti, F. [3 ]
Fabi, A. [3 ]
De Placido, S. [4 ]
Arpino, G. [4 ]
Marchetti, P. [5 ]
Botticelli, A. [5 ]
Pronzato, P. [6 ]
Martelli, E. [7 ]
机构
[1] Hlth Econ Res & Consulting, Studio Econ Sanit, Milan, Italy
[2] Publ Hosp Trust Garibaldi, Dept Med Oncol, Catania, Italy
[3] Regina Elena Inst Canc Res, Dept Med Oncol A, Rome, Italy
[4] Federico II Univ Hosp, Sch Med, Dept Endocrinol & Mol & Clin Oncol, Naples, Italy
[5] Publ Hosp Trust StAndrea, Dept Med Oncol, Rome, Italy
[6] Natl Canc Res Inst, Dept Med Oncol A, Genoa, Italy
[7] Celgene Srl, Hlth Econ, Milan, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S93 / S93
页数:1
相关论文
共 50 条
  • [31] Potentially Overestimated Efficacy of Nanoparticle Albumin-bound Paclitaxel compared with Solvent-based Paclitaxel in Breast Cancer: A Systemic Review and Meta-analysis
    Li, Bing-Xue
    Chen, Xin-Jie
    Ding, Tong-Jing
    Liu, Yi-Hua
    Ma, Ting-Ting
    Zhang, Gan-Lin
    Wang, Xiao-Min
    JOURNAL OF CANCER, 2021, 12 (17): : 5164 - 5172
  • [32] Moving beyond clinical trials: A real word multicenter Italian experience with albumin-bounded Paclitaxel (nab-Paclitaxel) in metastatic breast cancer
    Palumbo, R.
    Cazzaniga, M. E.
    Simoncini, E.
    Tondini, C.
    Piazza, E.
    Ferzi, A.
    Grasso, D.
    Danova, M.
    Tarenzi, E.
    Bernardo, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S290 - S290
  • [33] Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer
    Lazzaro, Carlo
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, 2024, 99 (01):
  • [34] Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer (vol 3, pg 165, 2009)
    Guan, Zhong-Zhen
    Li, Qing Li
    Feng, Fengyi
    Jiang, Zefei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (01) : 74 - 74
  • [35] Pharmacokinetics and Pharmacodynamics of nab-Paclitaxel in Patients With Solid Tumors: Disposition Kinetics and Pharmacology Distinct From Solvent-Based Paclitaxel
    Chen, Nianhang
    Li, Yan
    Ye, Ying
    Palmisano, Maria
    Chopra, Rajesh
    Zhou, Simon
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1097 - 1107
  • [36] Cost-Effectiveness of Nab-Paclitaxel and Gemcitabine Versus Gemcitabine Monotherapy for Patients with Unresectable Metastatic Pancreatic Cancer in Japan
    Morimoto, Kosuke
    Moriwaki, Kensuke
    Kaneyasu, Takako
    Nakayama, Hitomi
    Shimozuma, Kojiro
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 28 : 54 - 60
  • [37] Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis
    Lee, Hwaryeon
    Park, Sohyun
    Kang, Ji Eun
    Lee, Hee Min
    Kim, Sun Ah
    Rhie, Sandy Jeong
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [38] Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis
    Hwaryeon Lee
    Sohyun Park
    Ji Eun Kang
    Hee Min Lee
    Sun Ah Kim
    Sandy Jeong Rhie
    Scientific Reports, 10
  • [39] Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
    Cui, Jiujie
    Zhang, Xiaochen
    Qu, Shuli
    Wang, Liwei
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 691 - 697
  • [40] Nanoparticle Albumin-Bound Paclitaxel and Solvent-Based Paclitaxel as Chemotherapy Options for Patients With Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
    Gangannapalle, Mahesh
    Shahnoor, Husna
    Sattar, Lubna
    Nagi, Talwinder K.
    Al-Tekreeti, Marwah
    Khan, Muhammad Waqas
    Haseeb, Madiha D.
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)